Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 6-acetyl-4-(3-chloro-4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl-2h-benzo(b)pyran-3-ol
2. Sb 220453
3. Sb-220453
1. 175013-84-0
2. Sb-220453
3. Sb 220453
4. Tonabersate
5. Tonabersat [inn:ban]
6. Unii-2xd9773zmn
7. 2xd9773zmn
8. Tonabersat [inn]
9. N-((3s,4s)-6-acetyl-3-hydroxy-2,2-dimethylchroman-4-yl)-3-chloro-4-fluorobenzamide
10. Tonabersat [who-dd]
11. N-[(3s,4s)-6-acetyl-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-3-chloro-4-fluorobenzamide
12. Benzamide, N-[(3s,4s)-6-acetyl-3,4-dihydro-3-hydroxy-2,2-dimethyl-2h-1-benzopyran-4-yl]-3-chloro-4-fluoro-
13. Dtxsid40169923
14. 6-acetyl-4-(3-chloro-4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl-2h-benzo(b)pyran-3-ol
15. 2h-benzo(b)pyran-3-ol, 6-acetyl-4-(3-chloro-4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl-
16. N-[(3s,4s)-6-acetyl-3-hydroxy-2,2-dimethyl-3,4-dihydro-2h-1-benzopyran-4-yl]-3-chloro-4-fluorobenzamide
17. Usl-260
18. Tonabersatum
19. N-((3s,4s)-6-acetyl-3-hydroxy-2,2-dimethyl-3,4-dihydro-2h-1-benzopyran-4-yl)-3-chloro-4-fluorobenzamide
20. N-[(3s,4s)-6-acetyl-3,4-dihydro-3-hydroxy-2,2-dimethyl-2h-1-benzopyran-4-yl]-3-chloro-4-fluoro-benzamide
21. Chembl318191
22. Schembl5917016
23. Dtxcid9092414
24. Tonabersat, >=98% (hplc)
25. Xliirnopgjtbjd-rouuacijsa-n
26. Ex-a11063
27. Mfcd00944458
28. Akos015994581
29. Cs-0676
30. Db06578
31. Es-0039
32. Ncgc00379030-01
33. Hy-15204
34. Sb220453
35. Db-371002
36. Ns00069336
37. Brd-k36970462-001-01-6
38. Q27255763
39. (3s,4s)-6-acetyl-4-(3-chloro-4-fluorobenzamido)-3,4-dihydro-2,2-dimethyl-3-hydroxy-2h-1-benzopyran
40. (3s-cis)-n-(6-acetyl-3,4-dihydro-3-hydroxy-2,2 -(dimethyl-d6)-2h-1-benzopyran-4-yl)-3-chloro-4-fluorobenzamide
| Molecular Weight | 391.8 g/mol |
|---|---|
| Molecular Formula | C20H19ClFNO4 |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 75.6 |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 586 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in migraine and cluster headaches.
ABOUT THIS PAGE
38
PharmaCompass offers a list of Tonabersat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tonabersat manufacturer or Tonabersat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tonabersat manufacturer or Tonabersat supplier.
PharmaCompass also assists you with knowing the Tonabersat API Price utilized in the formulation of products. Tonabersat API Price is not always fixed or binding as the Tonabersat Price is obtained through a variety of data sources. The Tonabersat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tonabersat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tonabersat, including repackagers and relabelers. The FDA regulates Tonabersat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tonabersat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tonabersat supplier is an individual or a company that provides Tonabersat active pharmaceutical ingredient (API) or Tonabersat finished formulations upon request. The Tonabersat suppliers may include Tonabersat API manufacturers, exporters, distributors and traders.
Tonabersat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tonabersat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tonabersat GMP manufacturer or Tonabersat GMP API supplier for your needs.
A Tonabersat CoA (Certificate of Analysis) is a formal document that attests to Tonabersat's compliance with Tonabersat specifications and serves as a tool for batch-level quality control.
Tonabersat CoA mostly includes findings from lab analyses of a specific batch. For each Tonabersat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tonabersat may be tested according to a variety of international standards, such as European Pharmacopoeia (Tonabersat EP), Tonabersat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tonabersat USP).
